Skip to main content
SpringerLink
Log in

Apolipoprotein disorders

  • I. Apolipoproteins And Lipoproteins
  • 1. Biological And Clinical Features
  • Published:
Ricerca in clinica e in laboratorio

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Albers J. J.: Lecithin:cholesterol acyltransferase — Artery5, 61, 1979.

    PubMed  CAS  Google Scholar 

  2. Albers J. J., Adolphons J. L., Hazzard W. R.: Radioimmunoassay of human plasma Lp(a) lipoprotein — J. Lipid Res.18, 331, 1977.

    PubMed  CAS  Google Scholar 

  3. Albers J. J., Cabana V. G., Hazzard W. R.: Immunoassay of human plasma apolipoprotein B — Metabolism24, 1339, 1975.

    PubMed  CAS  Google Scholar 

  4. Assmann G.: Tangier-Krankheit. In:Schettler G., Greten H., Schlierf G., Seidel D. (Eds): Stoffwechselkrankheiten. Springer-Verlag, Berlin-Heidelberg-New York. (Handbuch der Inneren Medizin, vol. 5, part VII, chapt. 4, p. 461, 1976).

    Google Scholar 

  5. Assmann G.: Die Tangier-Krankheit — Klinik und Pathophysiologie — Klin. Wschr.57, 53, 1979.

    PubMed  CAS  Google Scholar 

  6. Assmann G.: Tangier disease and the possible role of high density lipoproteins in atherosclerosis — Atheroscler. Rev.6, 1, 1979.

    CAS  Google Scholar 

  7. Assmann G., Simantke O., Schaefer H.-E., Smooth E.: Characterization of high density lipoproteins in patients heterozygous for Tangier disease — J. clin. Invest.60, 1025, 1977.

    PubMed  CAS  Google Scholar 

  8. Assmann G., Smootz E., Adler K., Capurso A., Oette K.: The lipoprotein abnormality in Tangier disease. Quantitation of A apoproteins — J. clin. Invest.59, 565, 1977.

    PubMed  CAS  Google Scholar 

  9. Baker H. N., Delahunty T., Gotto A. M. Jr.,Jackson R. L.: The primary structure of high density apolipoprotein-glutamine-I — Proc. nat. Acad. Sci. (Wash.)71, 3631, 1974.

    CAS  Google Scholar 

  10. Breckenridge W. C., Little J. A., Steiner G., Chow A., Poapst M.: Hypertriglyceridemia associated with deficiency of apolipoprotein C-II — New Engl. J. Med.298, 1265, 1978.

    PubMed  CAS  Google Scholar 

  11. Brewer H. B. Jr.,Fairwell T., Larne A., Ronan R., Houser A., Bronzert T. J.: The amino acid sequence of human apo A-I, an apolipoprotein isolated from high density lipoproteins — Biochem. biophys. Res. Commun.80, 623, 1978.

    PubMed  CAS  Google Scholar 

  12. Brewer H. B. Jr.,Lux S. E., Ronan R., John K. M.: Amino acid sequence of human apo Lp-Gln-II (apo A-II), an apolipoprotein isolated from the high density lipoprotein complex — Proc. nat. Acad. Sci. (Wash.)69, 1304, 1972.

    CAS  Google Scholar 

  13. Brewer H. B., Shulman R., Herbert P., Ronan R., Wehrly K.: The complete amino acid sequence of alanine apolipoprotein (apo C-III), an apolipoprotein from human plasma very low density lipoproteins — J. biol. Chem.249, 4975, 1974.

    PubMed  CAS  Google Scholar 

  14. Brown W. V., Baginsky M. L.: Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein — Biochem. biophys. Res. Commun.46, 375, 1972.

    PubMed  CAS  Google Scholar 

  15. Brown M. S., Goldstein J. L., Fredrickson D. S.: Familial type 3 hyperlipoproteinemia. In:Stanbury J. B., Wyngaarden J. B., Fredrickson D. S., Goldstein J. L., Brown M. S. (Eds): The metabolic basis of inherited disease. McGraw-Hill, New York, 1982, chapt. 32. (In press).

    Google Scholar 

  16. Brown M. S., Kovanen P. T., Goldstein J. L.: Regulation of plasma cholesterol by lipoprotein receptors — Science212, 628, 1981.

    PubMed  CAS  Google Scholar 

  17. Capurso A., Pace L., Bonomo L., Catapano A. L., Schiliro G., La Rosa M., Assmann G.: New case of apoprotein C-II deficiency — Lanceti, 268, 1980.

    Google Scholar 

  18. Catapano A. L.: The distribution of apo C-II and apo C-III in very low density lipoproteins of normal and type IV subjects — Atherosclerosis35, 419, 1980.

    PubMed  CAS  Google Scholar 

  19. Chajek T., Fielding C. J.: Isolation and characterization of a human serum cholesteryl ester transfer protein — Proc. nat. Acad. Sci. (Wash.)75, 3445, 1978.

    CAS  Google Scholar 

  20. Chao Y.-S., Windler E. E., Chen G. C., Havel R. J.: Hepatic catabolism of rat and human lipoproteins in rats treated with 17 alpha-ethinyl estradiol — J. biol. Chem.254, 11360, 1979.

    PubMed  CAS  Google Scholar 

  21. Cox D. W., Breckenridge W. C., Little J. A.: Inheritance of apolipoprotein C-II deficiency with hypertriglyceridemia and pancreatitis — New Engl. J. Med.299, 1421, 1978.

    PubMed  CAS  Google Scholar 

  22. Crepaldi G., Fellin R., Baggio G., Augustin J., Greten H.: Lipoprotein and apoprotein, adipose tissue and hepatic lipoprotein lipase levels in patients with familial hyperchylomicronemia and their immediate family members. In:Gotto A. M. Jr.,Smith L. C., Allen B. (Eds): Atherosclerosis. Springer-Verlag, New York, 1980; vol. V, p. 250.

    Google Scholar 

  23. Curry M. D., McConathy W. J., Fesmire J. D., Alaupovic P.: Quantitative determination of human apolipoprotein C-III by electroimmunoassay — Biochim. biophys. Acta (Amst.)617, 503, 1980.

    CAS  Google Scholar 

  24. Ferrans V. I., Fredrickson D. S.: The pathology of Tangier disease. A light and electron microscopic study — Amer. J. Path.78, 101, 1975.

    PubMed  CAS  Google Scholar 

  25. Fielding C. J., Fielding P. E.: Regulation of human plasma lecithin: cholesterol acyltransferase activity by lipoprotein acceptor cholesteryl ester content — J. biol. Chem.256, 2102, 1981.

    PubMed  CAS  Google Scholar 

  26. Fielding P. E., Fielding C. J.: A cholesteryl ester transfer complex in human plasma — Proc. nat. Acad. Sci. (Wash.)77, 3327, 1980.

    CAS  Google Scholar 

  27. Fielding C. J., Shore V. G., Fielding P. E.: A protein cofactor of lecithin:cholesterol acyltransferase — Biochem. biophys. Res. Commun.46, 1493, 1972.

    PubMed  CAS  Google Scholar 

  28. Franceschini G., Sirtori C. R., Capurso A., Weisgraber K. H., Mahley R. W.: AI-Milano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family — J. clin. Invest.66, 892, 1980.

    PubMed  CAS  Google Scholar 

  29. Fredrickson D. S., Levy R. I., Lees R. S.: Fat transport in lipoproteins: an integrated approach to mechanisms and disorders — New Engl. J. Med.276, 32, 94, 148, 215, 273, 1967.

    Google Scholar 

  30. Fredrickson D. S., Morganroth J., Levy R. I.: Type III hyperlipoproteinemia: an analysis of two contemporary definitions — Ann. intern. Med.82, 150, 1975.

    PubMed  CAS  Google Scholar 

  31. Glomset J. A.: The plasma lecithin:cholesterol acyltransferase reaction — J. Lipid Res.9, 155, 1968.

    PubMed  CAS  Google Scholar 

  32. Green P. H. R., Glickman R. M., Riley J. W., Quinet E.: Human apolipoprotein A-IV. Intestinal origin and distribution in plasma — J. clin. Invest.65, 911, 1980.

    PubMed  CAS  Google Scholar 

  33. Gregg R. E., Zech L. A., Schaefer E. J., Brewer H. B. Jr.: Type III hyperlipoproteinemia: defective metabolism of an abnormal apolipoprotein E — Science211, 584, 1981.

    PubMed  CAS  Google Scholar 

  34. Havel R. J.: International Congress for Clinical Chemistry. Wien, 1981.

  35. Havel R. J., Chao Y.-S., Windler E. E., Kotite L., Guo L. S. S.: Isoprotein specificity in the hepatic uptake of apolipoprotein E and the pathogenesis of familial dysbetalipoproteinemia — Proc. nat. Acad. Sci. (Wash.)77, 4349, 1980.

    CAS  Google Scholar 

  36. Havel R. J., Goldstein J. L., Brown M. S.: Lipoproteins and lipid transport. In:Bondy P. K., Rosenberg L. E. (Eds): Metabolic control and disease. 8th ed., W. B. Saunders, Co., Philadelphia, 1980; chapt. 7, p. 393.

    Google Scholar 

  37. Havel R. J., Kane J. P.: Primary dysbetalipoproteinemia: predominance of a specific apolipoprotein species in triglyceride-rich lipoproteins — Proc. nat. Acad. Sci. (Wash.)70, 2015, 1973.

    CAS  Google Scholar 

  38. Havel R. J., Kotite L., Kane J.: Isoelectric heterogeneity of the cofactor protein for lipoprotein lipase and human blood plasma — Biochem. Med.21, 121, 1979.

    PubMed  CAS  Google Scholar 

  39. Havel R. J., Kotite L., Vigne J.-L., Kane J. P., Tun P., Phillips N., Chen G. C.: Radioimmunoassay of human arginine-rich apolipoprotein, apoprotein E. Concentration in blood and lipoproteins as affected by apoprotein E-3 deficiency — J. clin. Invest.66, 1351, 1980.

    PubMed  CAS  Google Scholar 

  40. Havel R. J., Shore V. G., Shore B., Biou D. M.: Role of the specific glycopeptides of human serum lipoproteins in the activation of lipoprotein lipase — Circulat. Res.27, 595, 1970.

    PubMed  CAS  Google Scholar 

  41. Hazzard W. R., Porte D., Bierman E. L.: Abnormal lipid composition of very low density lipoproteins in diagnosis of broad beta disease (type III hyperlipoproteinemia) — Metabolism21, 1009, 1972.

    PubMed  CAS  Google Scholar 

  42. Herbert P. N., Assmann G., Gotto A. M. Jr.,Fredrickson D. S.: Familial lipoprotein deficiency (abetalipoproteinemia, hypobetalipoproteinemia and Tangier disease). In:Stanbury M. S., Wyngaarden J. B., Fredrickson D. S., Goldstein J. L., Brown M. S. (Eds): The metabolic basis of inherited disease. McGraw-Hill, New York, 1982, chapt. 29. (In press).

    Google Scholar 

  43. Herbert P. N., Fredrickson D. S.: The hypobetalipoproteinemias. In:Schettler G., Greten H., Schlierf G., Seidel D. (Eds): Handbuch der Inneren Medizin, VII/4. Fettstoffwechsel. Springer-Verlag, Heidelberg, 1976; p. 485.

    Google Scholar 

  44. Herbert P. N., Gotto A. M. Jr.,Fredrickson D. S.: Familial lipoprotein deficiency (abetalipoproteinemia, hypobetalipoproteinemia and Tangier disease). In:Stanbury J. B., Wyngaarden J. B., Fredrickson D. S. (Eds): The metabolic basis of inherited disease. McGraw-Hill, New York, 1978; chapt. 28, p. 544.

    Google Scholar 

  45. Herbert P. N., Heinen R. J., Bausserman L. L., Henderson L. O., Musliner T. A.: Abetalipoproteinemia and hypobetalipoproteinemia: question still exceeds insights. In:Gotto A. M. Jr.,Smith L. C., Allen B. (Eds): Atherosclerosis. Proceedings of the Fifth International Symposium on Atherosclerosis. Springer-Verlag, New York, 1980; vol. V, p. 684.

    Google Scholar 

  46. Innerarity T. L., Mahley R. W., Weisgraber K. H., Bersot T. P.: Apoprotein (E-A-II) complex of human plasma lipoprotein. II. Receptor binding activity of a high density lipoprotein subfraction modulated by apo (E-A-II) complex — J. biol. Chem.253, 6289, 1978.

    PubMed  CAS  Google Scholar 

  47. Innerarity T. L., Pitas R. E., Mahley R. W.: Receptor binding of cholesterol-induced high-density lipoproteins containing predominantly apoprotein E to cultured fibroblasts with mutations at the low-density lipoprotein receptor locus — Biochemistry19, 4359, 1974.

    Google Scholar 

  48. Jackson R. L., Baker H. N., Gilliam E. B., Gotto A. M. Jr.: Primary structure of very low density apolipoprotein C-II of human plasma — Proc. nat. Acad. Sci. (Wash.)74, 1942, 1977.

    CAS  Google Scholar 

  49. Jackson R. L., Morrisett J. D., Gotto A. M. Jr.: Lipoproteins and lipid transport: structural and functional concepts. In:Levy R. I., Rifkind B. M. (Eds): Hyperlipidemia, diagnosis and therapy. Grune and Stratton, New York, 1977; p. 1.

    Google Scholar 

  50. Jackson R. L., Morrisett J. D., Gotto A. M. Jr.,Segrest J. P.: The mechanism of lipid-binding by plasma lipoproteins — Molec. cell. Biochem.6, 43, 1975.

    PubMed  CAS  Google Scholar 

  51. Jackson R. L., Morrisett J. D., Sparrow J. R., Segrest J. P., Pownall H. J., Smith L. C., Hoff H. F., Gotto A. M. Jr.: The interaction of apolipoprotein-serine with phosphatidylcholine — J. biol. Chem.249, 5314, 1974.

    PubMed  CAS  Google Scholar 

  52. Jackson R. L., Sparrow J. T., Baker H. N., Morrisett J. D., Taunton O. D., Gotto A. M. Jr.: The primary structure of apolipoprotein-serine — J. biol. Chem.249, 5308, 1974.

    PubMed  CAS  Google Scholar 

  53. Kane J. P., Hardman D. A., Paulus H. E.: Heterogeneity of apolipoprotein B: isolation of a new species from human chylomicrons — Proc. nat. Acad. Sci. (Wash.)77, 2465, 1980.

    CAS  Google Scholar 

  54. Kashyap M. L., Srivastava L. S., Chen C. Y., Perisutti G., Campbell M., Lutmer R. J. F., Glueck C. J.: Radioimmunoassay of human apolipoprotein C-II. A study in normal and hypertriglyceridemic subjects — J. clin. Invest.60, 171, 1977.

    PubMed  CAS  Google Scholar 

  55. Katz S. S., Small D. M., Brook I. G., Lees R. W.: The storage lipids in Tangier disease. A physical chemical study — J. clin. Invest.59, 1045, 1977.

    PubMed  CAS  Google Scholar 

  56. Kinnunen P. K. J., Jackson R. L., Smith L. C., Gotto A. M. Jr.,Sparrow J. T.: Activation of lipoprotein lipase by native and synthetic fragments of human plasma apolipoprotein C-II — Proc. nat. Acad. Sci. (Wash.)74, 4848, 1977.

    CAS  Google Scholar 

  57. Kostner G. M.: Studies of the composition and structure of human serum lipoproteins: isolation and partial characterization of apolipoprotein A-III — Biochim. biophys. Acta (Amst.)336, 383, 1974.

    CAS  Google Scholar 

  58. Kostner G. M.: Studies on the cofactor requirement for lecithin: cholesterol acyltransferase — Scand. J. clin. Lab. Invest.33 (Suppl. 137), 19, 1974.

    CAS  Google Scholar 

  59. Kostner G. M., Avogaro P., Cazzolato G., Marth E., Bittolo-Bon G., Quinci G. B.: Lipoprotein Lp(a) and the risk for myocardial infarction — Atherosclerosis38, 51, 1981.

    PubMed  CAS  Google Scholar 

  60. Kraus R. M., Herbert P. N., Levy R. I., Fredrickson D. S.: Further observations on the activation and inhibition of lipoprotein lipase by apolipoproteins — Circulat. Res.33, 403, 1973.

    Google Scholar 

  61. Kushwaha R. S., Hazzard W. R., Wahl P. W., Hoover J. J.: Type III hyperlipoproteinemia: diagnosis in whole plasma by apolipoprotein-E immunoassay — Ann. intern. Med.87, 509, 1977.

    PubMed  CAS  Google Scholar 

  62. La Rosa J. C., Levy R. I., Herbert P. N., Lux S. E., Fredrickson D. S.: A specific apoprotein activator for lipoprotein lipase — Biochem. biophys. Res. Commun.41, 57, 1970.

    Google Scholar 

  63. Levy R. I., Assmann G.: Type III-hyperlipoproteinemia. In:Schettler G., Greten H., Schlierf G., Seidel D. (Eds): Stoffwechselkrankheiten. Springer-Verlag, Berlin-Heidelberg-New York. (Handbuch der Inneren Medizin, vol. 5, part VII, chapt. 4, p. 301, 1976).

  64. Malloy M. J., Kane J. P., Hardman D. A., Hamilton R. L., Dalal K. B.: Normotriglyceridemic abetalipoproteinemia. Absence of the B-100 apolipoprotein — J. clin. Invest.67, 1441, 1981.

    PubMed  CAS  Google Scholar 

  65. Mao S. J. T., Jackson R. L., Gotto A. M., Jr.,Sparrow J. T.: Mechanism of lipid-protein interaction in the plasma lipoproteins: identification of a lipid-binding site in apolipoprotein A-II — Biochemistry20, 1676, 1981.

    PubMed  CAS  Google Scholar 

  66. Mao S. J. T., Sparrow J. T., Gilliam E. B., Gotto A. M. Jr.,Jackson R. L.: Mechanism of lipid-protein interaction in the plasma lipoproteins: the lipid-binding properties of synthetic fragments of apolipoprotein A-II — Biochemistry16, 4150, 1977.

    PubMed  CAS  Google Scholar 

  67. Masket B. H., Levy R. I., Fredrickson D. S.: The use of polyacrylamide electrophoresis in differentiating type III hyperlipoproteinemia — J. Lab. clin. Med.82, 794, 1973.

    Google Scholar 

  68. McConathy W. J., Alaupovic P.: Isolation and partial characterization of apolipoprotein D: a new protein moiety of the human plasma lipoprotein system —Febs Letters37, 178, 1973.

    PubMed  CAS  Google Scholar 

  69. Menzel H.-J., Kladetzky R. G., Assmann G.: One-step screening method for the polymorphism of apolipoproteins A-I, A-II and A-IV — J. Lipid Res. 1981. (Submitted for publication).

  70. Miller N. E., Rao S. N., Alaupovic P., Noble N., Slack J., Brunzell J. D., Lewis B.: Familial apolipoprotein C-II deficiency, plasma lipoproteins and apolipoproteins in heterozygous and homozygous subjects and the effects of plasma infusion — Europ. J. clin. Invest.11, 69, 1981.

    PubMed  CAS  Google Scholar 

  71. Mishkel M., Nazir D. J., Crother S.: A longitudinal assessment of lipid ratios in the diagnosis of type III hyperlipoproteinemia — Clin. chim. Acta58, 121, 1975.

    PubMed  CAS  Google Scholar 

  72. Morganroth J., Levy R. I., Fredrickson D. S.: The biochemical, clinical and genetic features of type III hyperlipoproteinemia — Ann. intern. Med.82, 158, 1975.

    PubMed  CAS  Google Scholar 

  73. Morrisett J. D., Jackson R. L., Gotto A. M. Jr.: Lipoproteins: structure and function — Ann. Rev. Biochem.44, 183, 1975.

    PubMed  CAS  Google Scholar 

  74. Musliner T. A., Herbert P. N., Church E. C.: Activation of lipoprotein lipase by native and acylated peptides of apolipoprotein C-II — Biochim. biophys. Acta (Amst.)573, 501, 1979.

    CAS  Google Scholar 

  75. Nestruck A. C., Suzue G., Marcel Y. L.: Studies on the polymorphism of human apolipoprotein A-I — Biochim. biophys. Acta (Amst.)617, 110, 1980.

    CAS  Google Scholar 

  76. Nichols A., Miller N. E., Lewis B.: High-density lipoprotein metabolism — Advanc. Lipid Res.17, 53, 1980.

    Google Scholar 

  77. Pitas R. E., Innerarity T. L., Mahley R. W.: Cell surface receptor binding of phospholipid-protein complexes containing differnet ratios of receptor-active and inactive E apoprotein — J. biol. Chem.255, 5454, 1980.

    PubMed  CAS  Google Scholar 

  78. Schmitz G., Assmann G.: Isolation of human serum HDL-1 by zonal ultracentrifugation — J. Lipid Res. 1981. (Submitted for publication).

  79. Schmitz G., Assmann G., Melnik B.: The role of lecithin: cholesterol acyltransferase in high density lipoprotein-3/high density lipoprotein-2 interconversion in man — Clin. chim. Acta 1981. (In press).

  80. Schneider J., Maurer M., Kaffarnik H.: Häufigkeit der Hyperlipoproteinämie Typ III bei elektrophoretisch nachweisbarer breiter-Bande — Klin. Wschr.52, 941, 1974.

    PubMed  CAS  Google Scholar 

  81. Schonfeld G., Lees R. S., George P. K., Pfleger B.: Assay of total plasma apolipoprotein B concentration in human subjects — J. clin. Invest.53, 1458, 1974.

    PubMed  CAS  Google Scholar 

  82. Segrest J. P., Jackson R. L., Morrisett J. D., Gotto A. M. Jr.: A molecular theory of lipid protein interactions in the plasma lipoproteins —Febs Letters38, 247, 1974.

    PubMed  CAS  Google Scholar 

  83. Shelbourne F. A., Quarfordt S. H.: A new apoprotein of human plasma very low density lipoproteins — J. biol. Chem.249, 1428, 1974.

    Google Scholar 

  84. Shepherd J., Bicker S., Lorimer A. R., Packard C. J.: Receptor-mediated low density lipoprotein catabolism in man — J. Lipid Res.20, 999, 1979.

    PubMed  CAS  Google Scholar 

  85. Shepherd J., Packard C. J., Bicker S., Lawrie T. D. V., Morgan H. G.: Cholestyramine promotes receptor-mediated low-density-lipoprotein catabolism — New Engl. J. Med.302, 1219, 1980.

    PubMed  CAS  Google Scholar 

  86. Shulman R. S., Herbert P. N., Wehrly K., Fredrickson D. S.: The complete amino acid sequence of C-I (Apo Lp-Ser), an apolipoprotein from human very low density lipoproteins — J. biol. Chem.250, 182, 1975.

    PubMed  CAS  Google Scholar 

  87. Smith L. C., Voyta J. C., Catapano A. L., Kinnunen P. K. J., Gotto A. M. Jr.,Sparrow J. T.: Activation of lipoprotein lipase by synthetic fragments of apo C-II. In:Gotto A. M. Jr.,Smith L. C., Allen B. (Eds). Atherosclerosis. Springer-Verlag, New York, 1980, vol. V, p. 397.

    Google Scholar 

  88. Soutar A. K., Garner C. W., Baker H. N., Sparrow J. T., Jackson R. L., Gotto A. M. Jr.,Smith L. C.: Effect of the human plasma apolipoproteins and phosphatidylcholine acyl donor on the activity of lecithin:cholesterol acyltransferase — Biochemistry14, 3057, 1975.

    PubMed  CAS  Google Scholar 

  89. Utermann G., Albrecht G., Steinmetz A.: Polymorphism of apolipoprotein E. I. Methodological aspects and diagnosis of hyperlipoproteinemia type III without ultracentrifugation — Clin. Genet.14, 351, 1978.

    PubMed  CAS  Google Scholar 

  90. Utermann G., Beisiegel U.: Apolipoprotein A-IV: a protein occurring in human mesenteric lymph chylomicrons and free in plasma — Europ. J. Biochem.99, 33, 1979.

    Google Scholar 

  91. Utermann G., Hees M., Steinmetz A.: Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinemia in man — Nature (Lond.)269, 604, 1977.

    CAS  Google Scholar 

  92. Utermann G., Jaeschke M., Menzel H.-J.: Familial hyperlipoproteinemia type III: deficiency of a specific apolipoprotein (apo E-III) in the very low density lipoproteins —Febs Letters56, 352, 1975.

    PubMed  CAS  Google Scholar 

  93. Utermann G., Langenbeck U., Beisiegel U., Weber W.: Genetics of the Apo-E-system in man — Amer. J. hum. Genet.32, 339, 1980.

    PubMed  CAS  Google Scholar 

  94. Utermann G., Lipp K., Wiegandt H.: Studies on the Lp(a)-lipoprotein of human serum. IV. The disaggregation of the Lp(a)-lipoprotein — Hum. Genet.14, 142, 1972.

    CAS  Google Scholar 

  95. Utermann G., Pruin N., Steinmetz A.: Effect of a single polymorphic gene locus on plasma lipid levels in man — Clin. Genet.15, 63, 1979.

    PubMed  CAS  Google Scholar 

  96. Utermann G., Steinmetz A., Haas J., Feusner G., Franceschini G.: Apolipoproteinopathies: rapid method for screening and characterization of genetic apolipoprotein A variants — J. biol. Chem. 1981. (In press).

  97. Utermann G., Vogelberg K. H., Steinmetz A., Schoenborn W., Pruin N., Jaeschke M., Hees M., Canzler H.: Polymorphism of apolipoprotein E — Clin. Genet.15, 37, 1979.

    PubMed  CAS  Google Scholar 

  98. Warnick G. R., Mayfield C., Albers J. J., Hazzard R. W.: Gel isoelectric focusing method for specific diagnosis of familial hyperlipoproteinemia type III — Clin. Chem.25, 279, 1979.

    PubMed  CAS  Google Scholar 

  99. Weidman W. S., Suarez B., Falko J. M., Witzum J. L., Kolar J., Raben M., Schonfeld G.: Type III hyperlipoproteinemia: development of a VLDL Apo E gel isoelectric focusing technique and application in family studies — J. Lab. clin. Med.93, 549, 1979.

    PubMed  CAS  Google Scholar 

  100. Weisgraber K. H., Bersot T. P., Mahley R. W.: Isolation and characterization of an apolipoprotein from the d < 1.006 lipoproteins of human and canine lymph homologous with the rat A-IV apoprotein — Biochem. biophys. Res. Commun.85, 287, 1978.

    PubMed  CAS  Google Scholar 

  101. Weisgraber K. H., Bersot T. P., Mahley R. W., Franceschini G., Sirtori C. R.: AI-Milano apoprotein. Isolation and characterization of a cysteine-containing variant of the AI apoprotein from human high density lipoproteins — J. clin. Invest.66, 901, 1980.

    PubMed  CAS  Google Scholar 

  102. Weisgraber K. H., Mahley R. W.: Apoprotein (E-A-II) complex of human plasma lipoproteins — J. biol. Chem.253, 6281, 1978.

    PubMed  CAS  Google Scholar 

  103. Weisgraber K. H., Rall S. C. Jr.,Mahley R. W.: Human E apoprotein heterogeneity: cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms — J. biol. Chem. 1981. (In press).

  104. Wu A.-L., Windmüller H. G.: Relative contributions by liver and intestine to individual plasma apolipoproteins in the rat — J. biol. Chem.254, 7316, 1979.

    PubMed  CAS  Google Scholar 

  105. Yamamura T., Sudo H., Ishikawa K., Yamamoto A.: Familial type I hyperlipoproteinemia caused by apolipoprotein C-II deficiency — Atherosclerosis34, 53, 1979.

    PubMed  CAS  Google Scholar 

  106. Zannis V. I., Breslow J. L.: Characterization of a unique human apolipoprotein E variant associated with type III hyperlipoproteinemia — J. biol. Chem.255, 1759, 1980.

    PubMed  CAS  Google Scholar 

  107. Zannis V. I., Breslow J. L.: Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and post-translational modification — Biochemistry20, 1033, 1981.

    PubMed  CAS  Google Scholar 

  108. Zannis V. I., Just P. W., Breslow J. L.: Human apolipoprotein E isoprotein subclasses are genetically determined — Amer. J. hum. Genet.33, 11, 1981.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Zentrallaboratorium der Medizinischen Einrichtungen, der Westfälischen Wilhelms-Universität, Domagkstrasse 3, 4400, Wünster/Westf., Bundesrepublik Deutschland

    Gerd Assmann & Hans-Jürgen Menzel

Authors
  1. Gerd Assmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hans-Jürgen Menzel
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Assmann, G., Menzel, HJ. Apolipoprotein disorders. La Ricerca Clin. Lab. 12, 63–81 (1982). https://doi.org/10.1007/BF02909310

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02909310

Key-words

Search

Navigation